Galafold 123 MG
Ended Awarded
- Contract number
- 36C24523N0481
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $20,125
Award facts
- Contract value 100% obligated
- $20,124.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded Amicus Therapeutics US, LLC a $20,124.91 firm fixed price delivery order for GALAFOLD 123 MG under the Pharmaceuticals and Drugs (FSS-61-IB) GSA Schedule. Amicus Therapeutics US, LLC is a subsidiary of Amicus Therapeutics, Inc., which is developing novel, first-in-class pharmaceuticals for rare and orphan diseases. The delivery order is for the drug GALAFOLD and has a potential value of $20,124.91. Performance will take place in Philadelphia, PA with an anticipated completion date of April 5, 2023. No set-aside designation was used for this award to support the Veterans Health Administration's efforts to provide quality care to veterans.
Quick answers
Who was awarded contract 36C24523N0481?
36C24523N0481 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 31, 2023.
How much is contract 36C24523N0481 worth?
The government has obligated $20,125 on 36C24523N0481.
Is contract 36C24523N0481 an order under another contract?
Yes. 36C24523N0481 is a delivery order under 36F79719D0108, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24523N0481 competed?
The extent of competition for 36C24523N0481 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award